[Crug formulation and liberation of the active ingredient in of chloroquine phosphate].
D002738:Chloroquine / Q000494:pharmacology* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D004304:Dosage Forms; D005260:Female; D006801:Humans; D006814:Hungary; D006886:Hydroxychloroquine / Q000494:pharmacology* / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D010710:Phosphates / Q000494:pharmacology* / Q000627:therapeutic use; D013057:Spectrum Analysis; D013608:Tablets, Enteric-Coated
D003692:Delayed-Action Preparations; D004304:Dosage Forms; D010710:Phosphates; D013608:Tablets, Enteric-Coated; D006886:Hydroxychloroquine; D002738:Chloroquine
Adatok a klorokiniumfoszfát gyógyszerformulálásának és in vitro hatóanyag-leadásának egyes kérdéseihez